India's Medplus Health slips; Nomura trims PT on earnings miss

MedPlus Health Services

05/08/2025 07:46

** Shares of Medplus Health Services MEDP.NS fall 4.8% to 874 rupees

** Stock marks steepest intraday pct loss since January 14

** Nomura maintains "buy" rating; cuts price target to 1,030 rupees from 1,050 rupees

** New PT implies 12.1% upside to last close, compared to previous PT's 14.2% upside

** Says Q1 results missed estimates due to higher employee expenses

** Brokerage lowers fiscal 2026 and 2027 operating EBITDA estimates by ~15%/22%, factoring in slower revenue growth and elevated overheads

** MEDP rated "strong buy" by six analysts on average; median target price is 1,087.5 rupees – data compiled by LSEG

** Stock up 5.2% YTD

 (Reporting by Rudra Pratap Singh in Bengaluru)

 ((rudrapratap.singh@thomsonreuters.com))